A Hyperliquid whale, undeterred by the BTC downturn, made a bet on a wide selection of altcoins, including older assets and memes.A Hyperliquid whale, undeterred by the BTC downturn, made a bet on a wide selection of altcoins, including older assets and memes.

Whale on Hyperliquid goes long across altcoins as traders eye a rebound

2025/11/17 17:50

After the recent crypto market downturn, assets quickly attempted a small recovery. A Hyperliquid whale has moved in with long bets on a basket of altcoins. 

A Hyperliquid whale injected over $3.6M to go long on a selection of altcoins. While the market is still volatile and sentiment is low, the whale bets on a directional move, or at least a short-term recovery. 

Hyperliquid whale goes long on a basket of altcoins, is a recovery coming?A Hyperliquid whale made a selection of altcoins, allocating $3.6M on long positions. The whale chose trending tokens, as well as riskier memes with the potential for a rapid recovery. | Source: Hyperliquid.

The whale selected blue chip tokens like ETH and BNB, as well as recently active coins like LTC. The mix also included meme tokens, expecting a directional move for FARTCOIN, PEPE, BONK, PNUT, and POPCAT. 

The whale also took up new movers like ASTER and MET, but also an older asset, AVAX, in expectations of a breakout. The whale’s selection signals that a market-wide rally may not be possible, but some altcoins are still seen as capable of moving forward with clear moves. 

The whale holds onto the positions, with an unrealized loss of $276K net, offset by some of the smaller altcoin gains. 

Hyperliquid whale bets on HYPE

Overall, the whale carried a net unrealized loss, mostly based on the performance of HYPE. The position carried an unrealized loss of $293K, while the whale paid over $8,400 in fees to keep holding. HYPE traded at $38.49, near its usual range, still awaiting a more significant breakout. 

HYPE open interest fluctuates around $1.4B, after a series of liquidations. HYPE carries over 68% long positions among Hyperliquid whales, in the third spot after BTC and ETH. 

The coin has constant support from traders, despite its mindshare dropping by over 46% recently. The return of whales to Hyperliquid also signals that the risk of the perpetual futures DEX has not discouraged all traders. 

Hyperliquid currently carries $7.4B in open interest, of which around $2.5B is allocated to smaller altcoins. 

Traders look for forgotten coins awaiting a breakout

The altcoin season index has recently recovered from a local low of 25 points to 43 points. While not all top 100 assets are expanding, there are enough coins and tokens with directional rallies. 

The long bets on AVAX also grew on Hyperliquid, with trading volumes increasing to a one-month peak. Open interest also grew to $257M, from a recent low of $200M. 

While altcoins are risky, a bounce from their recent lows, combined with leveraged trading, may produce bigger gains. 

Perpetual DEXs allow traders to bet on a breakout, without ending up with token holdings. Trending tokens also ensure there is sufficient liquidity to complete trades. 

Other recent shifts in sentiment show traders see altcoins as viable once again, after the October 11 liquidation. Among potential runners, UNI is seen as making a breakout to a new range, based on the platform’s success in 2025 and eventual profit sharing.

Sharpen your strategy with mentorship + daily ideas - 30 days free access to our trading program

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Novo Nordisk cuts cash prices for Wegovy, Ozempic

Novo Nordisk cuts cash prices for Wegovy, Ozempic

The post Novo Nordisk cuts cash prices for Wegovy, Ozempic appeared on BitcoinEthereumNews.com. Boxes of Ozempic and Wegovy made by Novo Nordisk at a pharmacy in London on March 8, 2024. Hollie Adams | Reuters Novo Nordisk on Monday said it has cut the direct-to-consumer prices of its blockbuster weight loss drug Wegovy and diabetes counterpart Ozempic, adding to efforts by the company and the Trump administration to make the treatments more accessible.  The Danish drugmaker is lowering the price of the drugs for existing cash-paying patients to $349 per month from $499 per month. But Novo Nordisk said the cash-pay cost of the highest dose of Ozempic will remain $499 per month.  Also on Monday, Novo Nordisk launched a temporary introductory offer, which will allow new cash-paying patients to access the two lowest doses of Wegovy and Ozempic for $199 per month for the first two months of treatment. After that period, people move to the new standard monthly direct-to-consumer price. The company’s introductory offer ends on March 31.  The announcements come days after President Donald Trump struck deals with Novo Nordisk and chief rival Eli Lilly to make their popular GLP-1 drugs easier for Americans to access and afford. Those agreements will involve cutting the prices the government pays for the drugs, introducing Medicare coverage of obesity drugs for the first time for certain patients and offering discounted medicines on the government’s new direct-to-consumer website launching in January called TrumpRx.  “Our new savings offers provide immediate impact, bringing forward greater cost savings for those who are currently without coverage or choose to self-pay,” said Dave Moore, Novo Nordisk’s head of U.S. operations, said in a release. “It is part of a larger strategy to expand access that includes building relationships with telehealth providers and major retailers, expanding coverage, and working with the Administration to lower costs for people living with chronic diseases like…
Share
BitcoinEthereumNews2025/11/17 21:30